ESSA Pharma Email Format
Biotechnology ResearchBritish Columbia, Canada11-50 Employees
ESSA Pharma is a clinical-stage biotechnology company headquartered in Vancouver, British Columbia. It focuses on developing therapies for prostate cancer, with its lead candidate, EPI-7386, aimed at disrupting the androgen receptor signaling pathway, a primary driver of prostate cancer growth. The company's work targets patients diagnosed with prostate cancer and clinicians seeking new treatment options within oncology. Positioned within the biotechnology research sector, ESSA operates as a small-to-mid-sized enterprise pursuing clinical development rather than commercial products at this stage. The company is part of the global life sciences ecosystem, advancing targeted approaches to cancer therapy from its Vancouver base.